5-Lipoxygenase.
Merck Frosst Centre for Therapeutic Research, Kirkland, Quebec, Canada.
A W
AW
Ford-Hutchinson
M
M
Gresser
R N
RN
Young
D058927:5-Lipoxygenase-Activating Proteins; D000818:Animals; D001094:Arachidonate 5-Lipoxygenase / Q000737:chemistry / Q000302:isolation & purification / Q000378:metabolism*; D002352:Carrier Proteins / Q000502:physiology; D002384:Catalysis; D003001:Cloning, Molecular; D004789:Enzyme Activation; D006801:Humans; D020024:Leukotriene Antagonists; D015289:Leukotrienes / Q000096:biosynthesis; D008024:Ligands; D016859:Lipoxygenase Inhibitors; D008565:Membrane Proteins / Q000502:physiology; D016297:Mutagenesis, Site-Directed; D013329:Structure-Activity Relationship
D058927:5-Lipoxygenase-Activating Proteins; C548592:ALOX5AP protein, human; D002352:Carrier Proteins; D020024:Leukotriene Antagonists; D015289:Leukotrienes; D008024:Ligands; D016859:Lipoxygenase Inhibitors; D008565:Membrane Proteins; D001094:Arachidonate 5-Lipoxygenase